Product Details
Neutrophil Gelatinase Associated Lipocalin Detection Reagent(NGAL)
NGAL overview
The gelatinase related lipid delivery protein (NGAL) is a small
molecule protein expressed in neutrophils. NGAL will be expressed
in renal tubular epithelial cells in large quantities and released
to urine and blood within 2 hours of acute renal injury. It is
significantly increased when sepsis is combined, which has the
characteristics of quick response, high specificity and small
influence by other factors. Therefore, it is used as a biomarker of
early sensitive acute renal injury, and can also be used to predict
the diagnosis of sepsis. High concentration NGAL can be detected in
urine and blood of patients with chronic kidney disease caused by
many diseases, so it is also used for diagnosis and monitoring of
chronic renal disease.
NGAL performance index
Detection range | sample size | Sample type | Test time |
50~5000ng/mL | 10μl | Whole blood / serum / plasma / urine | 10min |
Clinical significance of NGAL
- Early diagnosis and severity evaluation of acute kidney injury
- Diagnosis and prognosis of sepsis with nephropathy
- Diagnostic early warning of chronic kidney disease and secondary
kidney disease
- Evaluation of tissue specificity in tumor diseases
- It is related to the occurrence and development of cardiovascular
disease
- Effective markers for early diabetic nephropathy
Application Department
Nephrology, surgery, oncology, ICU, pediatrics, cardiology,
endocrinology, Urology, etc
Clinical comparison of NGAL
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments.
The company has always adhered to the core concept of "fast and
accurate, living up to life", committed to providing society with
excellent products and services, and contributing to the cause of
human health.
Company Profile
Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is
located in Dingluan Industrial Zone, Changyuan City, Henan
Province. The company covers an area of about 100 acres and the
initial investment is about 200 million yuan. The company has a
scientific and complete management system, a purification workshop
of national standards, and a fully functional inspection center. On
this basis, the company will continue to invest in research and
development, accumulate technical strength, update manufacturing
equipment, improve production technology, improve inspection
technology, improve product quality, and provide customers with
safe and effective in vitro diagnostic products.
Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, immune series,
microbial series and other reagents and supporting instruments.
The company has always adhered to the core concept of “fast and
accurate, living up to life”, committed to providing society with
excellent products and services, and contributing to the cause of
human health.